Navigation Links
Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Date:12/18/2007

tions of certain regulatory fees during development or at a time of market approval.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a privately-held pharmaceutical development company committed to world-class development and commercialization of promising clinical products to address the unmet medical needs of patients with life-threatening chronic and acute inflammatory diseases. In 2006, Anthera acquired worldwide rights (except Japan) to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase (PLA2) family -- a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes prostacyclins and other mediators of inflammation. These highly potent compounds inhibit novel upstream steps in the inflammation cascade and have the potential to address a variety of diseases including: acute chest syndrome, acute lung injury, acute respiratory distress syndrome, atherosclerosis, acute coronary syndrome, chronic obstructive pulmonary disease and psoriasis. In order to efficiently commercialize this platform, Anthera has brought together a proven management team with extensive experience in licensing, clinical research, development, and commercialization of anti-inflammatory products. For more information please visit http://www.anthera.com.

Contact:

Anne Bowdidge

(650) 218-6900

pr@anthera.com


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 20 The Department of H... members of priority groups that did not have prev...inics are being held statewide on Nov. 20-22. Frid...on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On ....m. to 8 p.m. ,, Individuals in the recommende...
(Date:11/20/2009)... ,, Reportlinker.com announces t...ts catalogue. ,, Global Markets for Breast Bio...com/p0164741/Global-Markets-for-Breast-Biopsy-Devi...=pr&utm_campaign=prnewswire ,, The global...ring loaded core needle market and vacuum assisted...
(Date:11/20/2009)...Newswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...nd Chief Executive Officer, and Greg Browne, Chief...l Piper Jaffray Health Care Conference in New York...The conference session and webcast will be audio o... Jaffray will host a webcast of the presentation l...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 1Oral Drug Ups Survival in Advanced Prostate Cancer Cases 54170 2National Breast Cancer Foundation Inc to Partner with XtremeSportsID 26amp 3B 238482 3B on Revolutionary Medical Identification Bracelet 54166 1National Breast Cancer Foundation Inc to Partner with XtremeSportsID 26amp 3B 238482 3B on Revolutionary Medical Identification Bracelet 54166 2National Breast Cancer Foundation Inc to Partner with XtremeSportsID 26amp 3B 238482 3B on Revolutionary Medical Identification Bracelet 54166 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 1Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 2Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 4Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 5
... generally consistent with oral olanzapine ...s, VENICE, Italy, June 23 Results from,olanzapin...ed that the,efficacy and safety profile of olanzap...exa(R) (olanzapine) with the exception of injectio...ce study (HGKA) and interim,findings from an ongoi...
...axoSmithKline,(NYSE: GSK ) today announced that t...extended the priority review period for PROMACTA(R...eviously treated patients,with chronic idiopathic ...e,to review the application. The Prescription Drug...er 19, 2008., On May 30, the Oncology Drugs Advis...
Other Medicine Technology:Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 2Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 3Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 4Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 5Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 6Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 7Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference 8GSK Update on FDA Review of Promacta(R) (Eltrombopag) 2
(Date:11/20/2009)...J, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharma...ting of Shareholders will be held on Monday, Decem...sider approval of two special resolutions. The fir...the sale of all or substantially all of the assets...or in the asset purchase agreement dated November ...
(Date:11/20/2009)...ON, Nov. 20 The United ...nate to make essential changes its health reform b...ion funding and conscience protection on abortion,...include strong provisions for adequate affordabili...e bill an "enormous disappointment" that creates n...
(Date:11/20/2009)... Senators and Congressmen in Competitive Re-elect...Care Vote , Washington, D...ssmen running for re-election next year in races d...Cook, may come to regret voting for House Speaker ...o a breaking Zogby International/ O’Leary Re...
(Date:11/20/2009)... 20 The American Dental...rug Administration (FDA) to establish appropriate ..., Citing concern about the safety of whitening p...nefit of professional consultation or examination ...ation of chemically based tooth whitening or bleac...
(Date:11/20/2009)... Israel, November 20 Car...://www.CVSLMEDICAL.COM , a leading,developer of ad...nounced that,the company,s Board of Directors has ... Canada and the Far East for its proprietary next-...l angioplasty (PCTA) procedures. , Cardio...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...aeli Agriculture minister Zeev Boim claimed on Sun...ries poultry. // The minister, who came under stro... to the bird flu, said that Israel has taken actio...net he stated that the cost of compensating farmer...
...tudy that is to appear in the May 1, 2006 issue of...ancer Society says that weight training// improves...een treated for breast cancer. A bi-weekly exercis...r, patients experience insomnia, weight gain, chro...
...nder the Revised National TB Control Programme (RN...dardized//, good quality treatment and diagnostic ... that about 50 - 60 % of HIV-positive people are m...esistant cases. He said this after releasing the R...
...ence Minister Pranab Mukherjee has urged the milit...e cutting edge of medical services, in the rapidly... challenges. // Military medical forces are th...he 16th Asia-Pacific Military Medicine Conference ...
...ef Minister of Bihar, Nitish Kumar assured that th...tricting the alarming spread of AIDS/HIV in the st...by the Udayan Sharma foundation, Samyak and the Na...hlighted the need for concerted efforts in creatin...
...with a mild fear of flying should take a deep brea...eir breath for six to 10 seconds, just before take...ssociation of German Psychiatrists (known by its G...ed affected persons to refrain from alcohol and ca...
Other Medicine News:Health News:Israel Claims Eradication Of Bird Flu In Poultry 2Health News:India to Implement National Action Plan against TB-HIV 2Health News:Pranab Mukherjee Urged Military Doctors To Remain On The Cutting Edge 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: